Ureteral Stent Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Ureteral Stent Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The ureteral stent market is expected to record a CAGR of 6.1% over the forecast period (2022-2027).

COVID-19 had a notable impact on the overall healthcare industry. As per the article published in 2020 under the title “Urinary stone management during the COVID-19 pandemic: a suggested approach and review of literature”, the study suggested that at-risk patients should be evaluated for urinary stones with ultrasonography after the lockdown period. The prolonged homestay has several negative effects on patients, including weight gain and physical inactivity, which may increase their chance of developing kidney stones. Furthermore, the article published in 2021 under the title “Challenges in Urology during the COVID-19 Pandemic”, stated that the issue of renal injury in COVID-19 patients needs a lot of attention since the chance of fluctuations in blood components is likely to be higher compared to other patients. Hence as per the factors mentioned above, COVID-19 had a significant impact on the ureteral stent market.

According to the American Urological Association, the most prevalent urological conditions are benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and ureteral stones. As per the same source, the average number of practicing urologists in the United States was 13,790 in 2021. Increased awareness, research and development, and government-funded programs related to the studies field boost market growth. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases celebrated national kidney month in March 2022. The source states that NIDDK raises awareness and focuses on building paths to better kidney care.

As per the aforementioned factors, the ureteral stent market is likely to grow over the forecast period. However, the risk of infection restrains the market growth.

Key Market TrendsUrinary Tract Infection Segment is Expected to Exibhit a Significant Growth Rate in the Ureteral Stent Market

The urinary tract infection segment is expected to exhibit significant growth in the ureteral stents market, owing to a higher incidence of urinary tract infection, kidney and bladder diseases, and higher adoption of ureteral stents. For instance, as per International Agency for Research on Cancer, the estimated number of people with bladder cancer is likely to be 7,356,11 by 2030. Furthermore, as per the same source, the mortality relating to bladder cancer is expected to be 2,861,64 by 2030. Since the anticipated number of cancers relating to the bladder is higher there is likely to be more adoption of ureteral stents and thus boosting the market growth.

The presence of competitors, research initiatives, and government funding fuels market growth. For instance, an article published in 2022 under the title “Allium Ureteral Stent as a Treatment for Ureteral Stricture: Results and Concerns”, stated that ‘Allium URS’ is likely to be considered a feasible and attractive treatment of ureteral strictures, due to its minimal invasiveness and it is best suited for the older population.

Because of the aforementioned factors, the total urinary tract infection segment is likely to face growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global ureteral stent market due to the growing burden of diseases related to the kidney. According to the Center for Disease Control and Prevention data in 2021, in the United States, nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease. Furthermore, despite the prevalence of kidney disease in the United States, as many as 9 in 10 people who have CKD are not aware they have the disease. Thus, the rising prevalence of chronic kidney disease is expected to be a major contributor to the ureteral stents market in this region.

Increased research and development in the field of ureteral stent boost the market growth. For instance, an article published in 2022 under the title “Design of a fully intraureteral stent and proof-of-concept in vivo evaluation”, special focus has been given to new coated and biodegradable ureteral stent designs. To lessen tissue irritation, these stents work to decrease inflammatory processes and microbial adherence to the stent.

As per the factors mentioned above, North America is expected to witness growth over the forecast period.

Competitive Landscape

Companies have been taking strategic initiatives such as collaborations, mergers, and acquisitions, which is expected to drive the market growth. Some of the companies, which are currently dominating the market are Uromed, Allium Medical, Coloplast, Beckton, Dickinson, and Company, Boston Scientific, Olympus Corporation, Cook Medical, and B. Braun SE.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.